Oriental Research Alliance of Acute Ischemic Stroke Given Endovascular Treatment: Technique Feasibility, Safety and Neuroprotective Effects of in Situ Ischemic Postconditioning in Patients Underwent Successful Endovascular Thrombectomy

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 95
Healthy Volunteers: f
View:

• Adult (age ≥ 18 to 95 years) patients with an occlusion of the internal carotid artery or M1 or M2 segment of the middle cerebral artery,;

• Patients with a score of at least 6 on the National Institutes of Health Stroke Scale (NIHSS) at admission and a score of 0 or 1 on the modified Rankin scale before the onset of stroke;

• Patients with a score of at least 6 on the Alberta Stroke Program Early CT score (ASPECTS) value;

• Baseline multimodal-CT imaging, including NCCT, CTA and CTP, performed at the trial-site hospital

• The modified thrombolysis in cerebral infarction (mTICI) scale 2b to 3 achieved in the infarct-related artery after the last thrombectomy attempt

Locations
Other Locations
China
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITING
Shanghai
Zhangzhou Municipal Hospital of Fujian Province
RECRUITING
Zhangzhou
Contact Information
Primary
Yueqi Zhu, PhD
zhuyueqi@hotmail.com
+86-21-18930177565
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2027-04
Participants
Target number of participants: 160
Treatments
rapid local ischemic postconditioning (RL-IPostC) group
RL-IPostC is performed immediately after successful reperfusion with 5 circules of balloon inflations in the ipsilateral internal carotid artery, each circulation includes inflation lasting 15 seconds followed by 15 seconds of deflation.
control group
no intervention was provided after successful reperfusion
Related Therapeutic Areas
Sponsors
Collaborators: Zhangzhou Municipal Hospital of Fujian Province
Leads: Shanghai Jiao Tong University Affiliated Sixth People's Hospital

This content was sourced from clinicaltrials.gov